|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
CTG004299531 |
| 003 |
DE-627 |
| 005 |
20230425165337.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210507s2023 xx |||||o 00| ||eng c |
| 035 |
|
|
|a (DE-627)CTG004299531
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)CTRI/2019/04/018828
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)NIL
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Correlation of two non-invasive methods of assessing fluid responsiveness after Passive Leg Raise test
|b Correlation Of Common Carotid Artery Blood Flow Parameters With Trans-thoracic Echocardiography Parameters For Assessing Volume Responsiveness After Passive Leg Raising Test In Critically Ill Patients
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 29-04-2019, Last updated: 2023-04-06
|
| 650 |
|
4 |
|a Medical Condition: Health Condition 1: K720- Acute and subacute hepatic failureHealth Condition 2: J471- Bronchiectasis with (acute) exacerbationHealth Condition 3: J180- Bronchopneumonia, unspecified organismHealth Condition 4: T222- Burn of second degree of shoulderand upper limb, except wrist and handHealth Condition 5: T300- Burn of unspecified body region, unspecified degreeHealth Condition 6: R570- Cardiogenic shockHealth Condition 7: K721- Chronic hepatic failureHealth Condition 8: T304- Corrosion of unspecified body region, unspecified degreeHealth Condition 9: R609- Edema, unspecifiedHealth Condition 10: A750- Epidemic louse-borne typhus feverdue to Rickettsia prowazekiiHealth Condition 11: R509- Fever, unspecifiedHealth Condition 12: R51- HeadacheHealth Condition 13: K729- Hepatic failure, unspecifiedHealth Condition 14: R571- Hypovolemic shockHealth Condition 15: R69- Illness, unspecifiedHealth Condition 16: J181- Lobar pneumonia, unspecified organismHealth Condition 17: J454- Moderate persistent asthmaHealth Condition 18: J438- Other emphysemaHealth Condition 19: R578- Other shockHealth Condition 20: R508- Other specified feverHealth Condition 21: J14- Pneumonia due to Hemophilus influenzaeHealth Condition 22: J150- Pneumonia due to Klebsiella pneumoniaeHealth Condition 23: J13- Pneumonia due to Streptococcus pneumoniaeHealth Condition 24: J189- Pneumonia, unspecified organismHealth Condition 25: J455- Severe persistent asthmaHealth Condition 26: J455- Severe persistent asthmaHealth Condition 27: R579- Shock, unspecifiedHealth Condition 28: L00- Staphylococcal scalded skin syndromeHealth Condition 29: L511- Stevens-Johnson syndromeHealth Condition 30: L513- Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndromeHealth Condition 31: R55- Syncope and collapseHealth Condition 32: T549- Toxic effects of unspecified corrosive substanceHealth Condition 33: L512- Toxic epidermal necrolysis [Lyell]Health Condition 34: A753- Typhus feve
|
| 650 |
|
4 |
|a Study Type: Observational
|
| 650 |
|
4 |
|a Recruitment Status: Recruiting
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2023) vom: 03. Apr.
|
| 773 |
1 |
8 |
|g year:2023
|g day:03
|g month:04
|
| 856 |
4 |
0 |
|u http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=31954
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2023
|b 03
|c 04
|
Klinische Studie